Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
O leitor tem acesso ilimitado s reportagens, artigos, fotos, vdeos e udios publicados e produzidos, de forma independente, pela redao da Instituio
Ruxolitinib (Opzelura) cream, a JAK inhibitor, is the first FDA-approved repigmentation therapy for non-segmental vitiligo (ages 12+)
(PubMed) Caldwell KL, Makhmudov A, Ely E, Jones RL, Wang RY
Time points: BL, baseline
& Philpott, D
This additional step was imperative for conducting direct evaluation of the hypothesis that LASSS interacts/reacts with HGF to augment its c-met binding affinity
US$ 26.62
US$ 28.97
US$ 23.08
US$ 28.12
US$ 29.76
US$ 21.32
